Mink Therapeutics Stock Price on March 22, 2024
| INKT Stock | USD 1.01 0.31 44.29% |
If you're considering investing in Mink Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mink Therapeutics stands at 1.01, as last reported on the 2nd of January, with the highest price reaching 1.23 and the lowest price hitting 0.68 during the day. Mink Therapeutics appears to be out of control, given 3 months investment horizon. Mink Therapeutics has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11% return per unit of risk over the last 3 months. By analyzing Mink Therapeutics' technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please exercise Mink Therapeutics' Downside Deviation of 4.5, mean deviation of 3.72, and Risk Adjusted Performance of 0.0956 to check out if our risk estimates are consistent with your expectations.
Mink Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Mink |
Sharpe Ratio = 0.1078
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INKT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.02 actual daily | 62 62% of assets are less volatile |
Expected Return
| 0.76 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Mink Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mink Therapeutics by adding it to a well-diversified portfolio.
Related Headline
Design Therapeutics Headline on 22nd of March 2024
Acquisition by Schmid John P. of 9156 shares of Design Thera... by Schmid John P.
Filed transaction by Design Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Mink Therapeutics Valuation on March 22, 2024
It is possible to determine the worth of Mink Therapeutics on a given historical date. On March 22, 2024 Mink was worth 0.87 at the beginning of the trading date compared to the closed value of 0.87. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mink Therapeutics stock. Still, in general, we apply an absolute valuation method to find Mink Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mink Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mink Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.91 | 0.91 | 0.86 | 0.89 | 47,544 | |
03/22/2024 | 0.87 | 0.89 | 0.86 | 0.87 | 32,781 |
| 0.88 | 0.92 | 0.87 | 0.92 | 44,368 |
| Backtest Mink Therapeutics | | | Mink Therapeutics History | | | Mink Therapeutics Valuation | Previous | Next |
Mink Therapeutics Trading Date Momentum on March 22, 2024
| On March 25 2024 Mink Therapeutics was traded for 0.92 at the closing time. The top price for the day was 0.92 and the lowest listed price was 0.87 . The trading volume for the day was 44.4 K. The trading history from March 25, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 5.75% . The trading delta at closing time against the current closing price is 9.20% . |
Mink Therapeutics Fundamentals Correlations and Trends
By evaluating Mink Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mink Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mink financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mink Therapeutics Stock history
Mink Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mink is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mink Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mink Therapeutics stock prices may prove useful in developing a viable investing in Mink Therapeutics
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc. Mink Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 33 people.
Mink Therapeutics Stock Technical Analysis
Mink Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mink Therapeutics Period Price Range
Low | January 2, 2025
| High |
0.00 | 0.00 |
Mink Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mink Therapeutics January 2, 2025 Market Strength
Market strength indicators help investors to evaluate how Mink Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mink Therapeutics shares will generate the highest return on investment. By undertsting and applying Mink Therapeutics stock market strength indicators, traders can identify Mink Therapeutics entry and exit signals to maximize returns
Mink Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mink Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Mink Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mink to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0956 | |||
| Jensen Alpha | 0.7461 | |||
| Total Risk Alpha | 0.7322 | |||
| Sortino Ratio | 0.1655 | |||
| Treynor Ratio | 10.61 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.